Literature DB >> 21221243

Clinical features of colorectal cancer detected by the national cancer screening program.

Dae-Do Park1, Rumi Shin, Ji-Sun Kim, Heung-Kwon Oh, Seung-Yong Jeong, Kyu Joo Park, Jae-Gahb Park.   

Abstract

PURPOSE: Since 2004, the National Cancer Screening Program of Korea has included colorectal cancer screening based on primary screening with the fecal occult blood test (FOBT). We report on the clinical features of colorectal cancer detected by the National Cancer Screening Program.
METHODS: We retrospectively analyzed 577 patients who underwent elective surgery for colorectal cancer at the Seoul National University Hospital between January 2008 and December 2009. We compared the clinical features of colorectal cancers detected by the National Cancer Screening Program (NCSP group) with those of the control group in terms of age, gender, preoperative symptom, location of the tumor, surgical technique and tumor-node-metastasis (TNM) stage.
RESULTS: Age, gender, location of the tumor and operation types were not different between the two groups. The proportion of asymptomatic patients was significantly higher in the NCSP group than it was in the control group (86.5% vs. 20.0%; P < 0.001). The proportion of less invasive lesions (T1 or T2) was significantly higher in the NCSP group (46.3% vs. 27.7%; P = 0.002). The pathologic stages of the colorectal cancers in the NCSP group were I, 40.3%; II, 17.9%; III, 40.3% and IV, 1.5% whereas in the control group, they were I, 20.8%; II, 32.9%; III, 34.9% and IV, 11.4%. The proportion of stage I cancer was significantly higher in the NCSP group than in the control group (40.3% vs. 20.8%; P = 0.006).
CONCLUSION: Our study demonstrates the FOBT in the NCSP is effective in early detection of colorectal cancer.

Entities:  

Keywords:  FOBT; National Cancer Screening Program

Year:  2010        PMID: 21221243      PMCID: PMC3017978          DOI: 10.3393/jksc.2010.26.6.420

Source DB:  PubMed          Journal:  J Korean Soc Coloproctol        ISSN: 2093-7822


  18 in total

1.  The best screening test for colorectal cancer--a personal choice.

Authors:  S H Woolf
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence.

Authors:  F Citarda; G Tomaselli; R Capocaccia; S Barcherini; M Crespi
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

3.  The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Authors:  J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

Review 4.  Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

Authors:  P Hewitson; P Glasziou; L Irwig; B Towler; E Watson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

5.  Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.

Authors:  S Vijan; E W Hwang; T P Hofer; R A Hayward
Journal:  Am J Med       Date:  2001-12-01       Impact factor: 4.965

6.  Using colonoscopy to screen for colorectal cancer.

Authors:  D F Ransohoff; C A Lang
Journal:  Am J Gastroenterol       Date:  1994-10       Impact factor: 10.864

7.  Experience of 1446 rectal cancer patients in Korea and analysis of prognostic factors.

Authors:  Y J Park; E G Youk; H S Choi; S U Han; K J Park; K U Lee; K J Choe; J G Park
Journal:  Int J Colorectal Dis       Date:  1999-04       Impact factor: 2.571

8.  Single immunochemical fecal occult blood test for detection of colorectal neoplasia.

Authors:  Dae Kyung Sohn; Seung-Yong Jeong; Hyo Seong Choi; Seok-Byung Lim; Jin Myeong Huh; Dae-Hyun Kim; Dae Yong Kim; Young Hoon Kim; Hee Jin Chang; Kyung Hae Jung; Joong-Bae Ahn; Hyun Kyung Kim; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

9.  Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database.

Authors:  Hai-Rim Shin; Young-Joo Won; Kyu-Won Jung; Hyun-Joo Kong; Seon-Hee Yim; Jung-Kyu Lee; Hong-In Noh; Jong-Koo Lee; Paola Pisani; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-12-31       Impact factor: 4.679

Review 10.  Current and evolving strategies for colorectal cancer screening.

Authors:  James Helm; Junsung Choi; Rebecca Sutphen; James S Barthel; Terrance L Albrecht; Thomas N Chirikos
Journal:  Cancer Control       Date:  2003 May-Jun       Impact factor: 3.302

View more
  2 in total

1.  Clinicopathologic factors affecting recurrence after curative surgery for stage I colorectal cancer.

Authors:  Min Ae Keum; Seok-Byung Lim; Sun A Kim; Yong Sik Yoon; Chan Wook Kim; Chang Sik Yu; Jin Cheon Kim
Journal:  J Korean Soc Coloproctol       Date:  2012-02-29

2.  Early colorectal epithelial neoplasm in Korea: a multicenter survey of pathologic diagnosis.

Authors:  Yun Kyung Kang; So-Young Jin; Mee Soo Chang; Jung Yeon Kim; Gyeong Hoon Kang; Hye Seung Lee; Jin Hee Sohn; Ho Sung Park; Kye Won Kwon; Mi Jin Gu; Young Hee Maeng; Jong Eun Joo; Haeng Ji Kang; Hee Kyung Kim; Kee-Taek Jang; Mi Ja Lee; Hee Kyung Chang; Joon Mee Kim; Hye Seung Han; Won Ae Lee; Yoon Jung Choi; Dong Wook Kang; Sunhoo Park; Jae Hyuk Lee; Mee-Yon Cho
Journal:  Korean J Pathol       Date:  2013-06-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.